MANGOCEUTICALS INC (MGRX) Stock Price & Overview

NASDAQ:MGRX • US56270V2051

Current stock price

0.3561 USD
-0.02 (-4.33%)
At close:
0.3332 USD
-0.02 (-6.43%)
After Hours:

The current stock price of MGRX is 0.3561 USD. Today MGRX is down by -4.33%. In the past year, price decreased by -92.02%.

MGRX Key Statistics

52-Week Range0.3311 - 5.2
Current MGRX stock price positioned within its 52-week range.
1-Month Range0.3311 - 0.689
Current MGRX stock price positioned within its 1-month range.
Market Cap
5.48M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-3.03
Dividend Yield
N/A

MGRX Stock Performance

Today
-4.33%
1 Week
-9.44%
1 Month
N/A
3 Months
-50.06%
Longer-term
6 Months -84.17%
1 Year -92.02%
2 Years -89.05%
3 Years -97.92%
5 Years N/A
10 Years N/A

MGRX Stock Chart

MANGOCEUTICALS INC / MGRX Daily stock chart

MGRX Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to MGRX. When comparing the yearly performance of all stocks, MGRX is a bad performer in the overall market: 98.12% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

MGRX Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to MGRX. MGRX may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MGRX Earnings

On November 14, 2025 MGRX reported an EPS of -0.69 and a revenue of 80.00K.

Next Earnings DateMar 20, 2026
Last Earnings DateNov 14, 2025
PeriodQ3 / 2025
EPS Reported-$0.69
Revenue Reported80K
EPS Surprise %
Revenue Surprise %

MGRX Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

MGRX Groups

Sector & Classification

Sub-Industry
Drug Retail
Index Membership

MGRX Financial Highlights

Over the last trailing twelve months MGRX reported a non-GAAP Earnings per Share(EPS) of -3.03. The EPS increased by 48.53% compared to the year before.


Income Statements
Revenue(TTM)467.00K
Net Income(TTM)-20.12M
Industry RankSector Rank
PM (TTM) N/A
ROA -121.68%
ROE -127.89%
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%30.84%
Sales Q2Q%-40.03%
EPS 1Y (TTM)48.53%
Revenue 1Y (TTM)-38.15%

MGRX Ownership

Ownership
Inst Owners16.49%
Shares15.39M
Float13.69M
Ins Owners11.05%
Short Float %12.69%
Short Ratio0.2

About MGRX

Company Profile

MGRX logo image Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. The company has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.

Company Info

IPO: 2023-03-21

MANGOCEUTICALS INC

15110 Dallas Pkwy, Suite 600

Dallas TEXAS US

Employees: 0

MGRX Company Website

MGRX Investor Relations

Phone: 18336264679

MANGOCEUTICALS INC / MGRX FAQ

What does MGRX do?

Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. The company has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.


Can you provide the latest stock price for MANGOCEUTICALS INC?

The current stock price of MGRX is 0.3561 USD. The price decreased by -4.33% in the last trading session.


Does MGRX stock pay dividends?

MGRX does not pay a dividend.


How is the ChartMill rating for MANGOCEUTICALS INC?

MGRX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


How many employees does MANGOCEUTICALS INC have?

MANGOCEUTICALS INC (MGRX) currently has 0 employees.


What is the ownership structure of MANGOCEUTICALS INC (MGRX)?

You can find the ownership structure of MANGOCEUTICALS INC (MGRX) on the Ownership tab.


What is the outstanding short interest for MANGOCEUTICALS INC?

The outstanding short interest for MANGOCEUTICALS INC (MGRX) is 12.69% of its float.